Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 18.17 billion as of February 5, 2025. Its market cap has decreased by -51.68% in one year.

Market Cap

18.17B

Enterprise Value

17.41B

Revenue

3.10B

Ranking

n/a

PE Ratio

148.47

Stock Price

11.16

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.17B, an increase of 33.25%. That is a compound annual growth rate of 2.04%.

Market Cap History

Date	Market Cap	% Change
Feb 5, 2025	18.17B	-5.96%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	283.91B
Shenzhen Mindray Bio-Medical Electronics	281.06B
WuXi AppTec	158.63B
Zhangzhou Pientzehuang Pharmaceutical.,	122.18B
Aier Eye Hospital Group	114.63B
Yunnan Baiyao Group Co.,Ltd	103.34B
Shanghai United Imaging Healthcare	101.87B
Beijing Wantai Biological Pharmacy Enterprise	86.14B

Market Cap Rankings